Literature DB >> 23562064

Mutual interaction between human multipotent adult progenitor cells and NK cells.

Sandra A Jacobs1, Jeroen Plessers, Jef Pinxteren, Valerie D Roobrouck, Catherine M Verfaillie, Stefaan W Van Gool.   

Abstract

Human multipotent adult progenitor cells (hMAPCs) are isolated from bone marrow with a more extensive expansion capacity compared to human mesenchymal stem cells (hMSCs) and with the ability to differentiate into endothelium. Like hMSCs, hMAPCs inhibit T-cell proliferation induced by alloantigens. In this study, we tested the interaction between hMAPCs and natural killer (NK) cells. We assessed the susceptibility of hMAPCs to NK cell-mediated lysis and the immunomodulation of hMAPCs on NK cell function during IL-2-driven stimulation and the cytolytic effector phase. Human MAPCs express the ligands PVR and ULBP-2/5/6, which are recognized by activating NK cell receptors. However, they also express MHC class I molecules, which induce inhibitory signals in NK cells. Freshly isolated NK cells at different effector:target ratios did not kill hMAPCs as assessed by an MTT and (51)Cr-release assay, while hMAPCs impaired the cytotoxic activity of resting NK cells against the NK-sensitive K562 leukemia cell line. By contrast, IL-2-stimulated NK cells were capable of killing hMAPCs, and preactivated NK cells were not influenced during their cytotoxic effector function against K562 cells by hMAPCs. When added during the 6-day preactivation phase with IL-2, hMAPCs dose-dependently reduced NK cell proliferation in an IDO-dependent manner, but they did not influence the induction of cytotoxic capacity by IL-2. This study indicates that human MAPCs mutually interact with NK cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23562064     DOI: 10.3727/096368913X665585

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  5 in total

1.  Clinical-Grade Human Multipotent Adult Progenitor Cells Block CD8+ Cytotoxic T Lymphocytes.

Authors:  Jeroen Plessers; Emily Dekimpe; Matthias Van Woensel; Valerie D Roobrouck; Dominique M Bullens; Jef Pinxteren; Catherine M Verfaillie; Stefaan W Van Gool
Journal:  Stem Cells Transl Med       Date:  2016-07-27       Impact factor: 6.940

2.  Using miRNA-mRNA Interaction Analysis to Link Biologically Relevant miRNAs to Stem Cell Identity Testing for Next-Generation Culturing Development.

Authors:  Marian A E Crabbé; Kristel Gijbels; Aline Visser; David Craeye; Sara Walbers; Jef Pinxteren; Robert J Deans; Wim Annaert; Bart L T Vaes
Journal:  Stem Cells Transl Med       Date:  2016-04-13       Impact factor: 6.940

3.  Multipotent adult progenitor cells improve the hematopoietic function in myelodysplasia.

Authors:  Valerie D Roobrouck; Esther Wolfs; Michel Delforge; Dorien Broekaert; Soumen Chakraborty; Kathleen Sels; Thomas Vanwelden; Bryan Holvoet; Larissa Lhoest; Satish Khurana; Shubham Pandey; Chloé Hoornaert; Peter Ponsaerts; Tom Struys; Nancy Boeckx; Peter Vandenberghe; Christophe M Deroose; Catherine M Verfaillie
Journal:  Cytotherapy       Date:  2017-06       Impact factor: 5.414

4.  Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells.

Authors:  Stylianos Ravanidis; Jeroen F J Bogie; Raf Donders; David Craeye; Robert W Mays; Robert Deans; Kristel Gijbels; Annelies Bronckaers; Piet Stinissen; Jef Pinxteren; Niels Hellings
Journal:  Stem Cell Res Ther       Date:  2015-09-16       Impact factor: 6.832

5.  Immunoregulatory effects of multipotent adult progenitor cells in a porcine ex vivo lung perfusion model.

Authors:  An Martens; Sofie Ordies; Bart M Vanaudenaerde; Stijn E Verleden; Robin Vos; Dirk E Van Raemdonck; Geert M Verleden; Valerie D Roobrouck; Sandra Claes; Dominique Schols; Eric Verbeken; Catherine M Verfaillie; Arne P Neyrinck
Journal:  Stem Cell Res Ther       Date:  2017-07-05       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.